Impact of Effective Global Tuberculosis Control on Health and Economic Outcomes in the United States
Menzies NA, Bellerose M, Testa C, Swartwood N, Malyuta Y, Cohen T, Marks SM, Hill AN, Date AA, Maloney SA, Bowden SE, Grills AW, Salomon JA. Impact of Effective Global Tuberculosis Control on Health and Economic Outcomes in the United States. American Journal Of Respiratory And Critical Care Medicine 2020, 202: 1567-1575. PMID: 32645277, PMCID: PMC7706168, DOI: 10.1164/rccm.202003-0526oc.Peer-Reviewed Original ResearchConceptsGlobal TB controlTB incidence trendsEnd TB StrategyTB controlTB casesIncidence trendsEconomic burdenWorld Health Organization's End TB StrategyTB incidence rateGlobal tuberculosis controlHigh-burden countriesTotal economic burdenMajor health benefitsBase case scenarioBirth countryTB incidenceTB epidemiologyTuberculosis controlTB StrategyIncidence rateHealthcare costsIncidence reductionInfection riskTuberculosisSubstantial healthTime Since Infection and Risks of Future Disease for Individuals with Mycobacterium tuberculosis Infection in the United States
Menzies NA, Swartwood N, Testa C, Malyuta Y, Hill AN, Marks SM, Cohen T, Salomon JA. Time Since Infection and Risks of Future Disease for Individuals with Mycobacterium tuberculosis Infection in the United States. Epidemiology 2020, 32: 70-78. PMID: 33009253, PMCID: PMC7707158, DOI: 10.1097/ede.0000000000001271.Peer-Reviewed Original ResearchConceptsLatent TB infectionMycobacterium tuberculosis infectionTB infectionTuberculosis infectionTB natural historyRisk of tuberculosisMost TB casesRate of progressionYounger age groupsLower future riskTransmission dynamic modelTB casesTB riskPrevalent infectionProgression riskLifetime riskRisk factorsIncidence trendsClinical diseaseCumulative riskGeneral populationAverage ageNew infectionsUS populationAge groups